Nomonde Ngema, 21, who was born with HIV, not only tackles the stigma on TikTok by sharing her journey, she also takes on ...

From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

Gilead Sciences, the maker of a twice-a-year anti-HIV injection, has approached South Africa’s medicine regulator to discuss ...

Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...

In recent years the option to purchase medications from India has gained significant popularity offering a reliable and affordable solution for people worldwide India has emerged as a trusted source f ...

HIV Research for Prevention Conference ANALYSIS | SETHI NCUBE | The 5th HIV Research for Prevention Conference (HIVR4P 2024) ...

Given recent approvals and a promising pipeline, new biomedical HIV prevention tools for women have the potential to ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

mostly tied to patients failing to take HIV medications consistently, and in all cases returned to very low or undetectable levels. "This demonstrates the safety and the fantastic outcomes that we ...

that is distinct from HIV, an opportunistic CNS infection or malignancy, previously undiagnosed 'AIDS dementia complex', delirium, medication-induced psychosis, and 'primary HIV psychosis'.